Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sotera Health (SHC) EBITDA (2020 - 2025)

Sotera Health (SHC) has 6 years of EBITDA data on record, last reported at $50.5 million in Q4 2025.

  • For Q4 2025, EBITDA rose 170.84% year-over-year to $50.5 million; the TTM value through Dec 2025 reached $176.4 million, up 347.8%, while the annual FY2025 figure was $176.4 million, 347.8% up from the prior year.
  • EBITDA reached $50.5 million in Q4 2025 per SHC's latest filing, up from $31.2 million in the prior quarter.
  • Across five years, EBITDA topped out at $89.1 million in Q2 2025 and bottomed at -$262.4 million in Q4 2022.
  • Average EBITDA over 5 years is $2.1 million, with a median of $6.5 million recorded in 2021.
  • Peak YoY movement for EBITDA: crashed 3159.33% in 2022, then surged 630.93% in 2025.
  • A 5-year view of EBITDA shows it stood at $58.9 million in 2021, then tumbled by 545.32% to -$262.4 million in 2022, then soared by 122.92% to $60.1 million in 2023, then plummeted by 218.57% to -$71.3 million in 2024, then soared by 170.84% to $50.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $50.5 million in Q4 2025, $31.2 million in Q3 2025, and $89.1 million in Q2 2025.